ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
hottod
|
12K |
6.2M |
12 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
12K
|
6.2M
|
12
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
hottod
|
12K |
6.2M |
21 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
12K
|
6.2M
|
21
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
hottod
|
12K |
6.2M |
40 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
12K
|
6.2M
|
40
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
hottod
|
12K |
6.2M |
31 |
25/02/24 |
25/02/24 |
ASX - By Stock
|
12K
|
6.2M
|
31
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Comment on research report
|
|
hottod
|
316 |
169K |
14 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
316
|
169K
|
14
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Comment on research report
|
|
hottod
|
316 |
169K |
68 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
316
|
169K
|
68
|
|
ASX - By Stock
|
PNV |
Re:
The Clinicians Speak
|
|
hottod
|
1.0K |
416K |
29 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
1.0K
|
416K
|
29
|
|
ASX - By Stock
|
PNV |
Re:
The Clinicians Speak
|
|
hottod
|
1.0K |
416K |
25 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
1.0K
|
416K
|
25
|
|
ASX - By Stock
|
PNV |
Re:
The Clinicians Speak
|
|
hottod
|
1.0K |
416K |
14 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
1.0K
|
416K
|
14
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Comment on research report
|
|
hottod
|
316 |
169K |
31 |
21/02/24 |
21/02/24 |
ASX - By Stock
|
316
|
169K
|
31
|
|
ASX - By Stock
|
PNV |
Re:
The Clinicians Speak
|
|
hottod
|
1.0K |
416K |
76 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
1.0K
|
416K
|
76
|
|
ASX - By Stock
|
PNV |
Re:
The Clinicians Speak
|
|
hottod
|
1.0K |
416K |
36 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
1.0K
|
416K
|
36
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Comment on research report
|
|
hottod
|
316 |
169K |
96 |
17/02/24 |
17/02/24 |
ASX - By Stock
|
316
|
169K
|
96
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Comment on research report
|
|
hottod
|
316 |
169K |
184 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
316
|
169K
|
184
|
|
ASX - By Stock
|
PYC Biotech |
Re:
PYC Chart and Technical Analysis
|
|
hottod
|
188 |
87K |
29 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
188
|
87K
|
29
|
|
ASX - By Stock
|
PNV |
Re:
The Clinicians Speak
|
|
hottod
|
1.0K |
416K |
40 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
1.0K
|
416K
|
40
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Notification regarding unquoted securities - NEU
|
|
hottod
|
32 |
17K |
40 |
08/02/24 |
08/02/24 |
ASX - By Stock
|
32
|
17K
|
40
|
|
ASX - By Stock
|
PNV |
Re:
PNV Media Thread
|
|
hottod
|
3.2K |
1.4M |
70 |
08/02/24 |
08/02/24 |
ASX - By Stock
|
3.2K
|
1.4M
|
70
|
|
ASX - By Stock
|
NEU |
Re:
Rare paediatric disease priority review
|
|
hottod
|
30 |
20K |
42 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
30
|
20K
|
42
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
hottod
|
843 |
394K |
48 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
843
|
394K
|
48
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Q4 2023 quarterly activity report
|
|
hottod
|
24 |
11K |
71 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
24
|
11K
|
71
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
hottod
|
481 |
226K |
32 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
481
|
226K
|
32
|
|
ASX - By Stock
|
PNV |
Re:
PNV Media Thread
|
|
hottod
|
3.2K |
1.4M |
21 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
3.2K
|
1.4M
|
21
|
|
ASX - By Stock
|
PNV |
Re:
PNV Media Thread
|
|
hottod
|
3.2K |
1.4M |
18 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
3.2K
|
1.4M
|
18
|
|
ASX - By Stock
|
PNV |
Re:
PNV Media Thread
|
|
hottod
|
3.2K |
1.4M |
10 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
3.2K
|
1.4M
|
10
|
|
ASX - By Stock
|
PNV |
Re:
PNV Media Thread
|
|
hottod
|
3.2K |
1.4M |
34 |
29/01/24 |
29/01/24 |
ASX - By Stock
|
3.2K
|
1.4M
|
34
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
hottod
|
481 |
226K |
26 |
27/01/24 |
27/01/24 |
ASX - By Stock
|
481
|
226K
|
26
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
hottod
|
843 |
394K |
11 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
843
|
394K
|
11
|
|
ASX - By Stock
|
PNV |
Re:
Ann: 1H24 Trading Result (unaudited)
|
|
hottod
|
135 |
50K |
52 |
24/01/24 |
24/01/24 |
ASX - By Stock
|
135
|
50K
|
52
|
|
ASX - By Stock
|
PNV |
Re:
Ann: 1H24 Trading Result (unaudited)
|
|
hottod
|
135 |
50K |
71 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
135
|
50K
|
71
|
|
ASX - By Stock
|
PNV |
Re:
Ann: 1H24 Trading Result (unaudited)
|
|
hottod
|
135 |
50K |
22 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
135
|
50K
|
22
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
hottod
|
1.3K |
703K |
22 |
20/01/24 |
20/01/24 |
ASX - By Stock
|
1.3K
|
703K
|
22
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
hottod
|
1.3K |
703K |
29 |
20/01/24 |
20/01/24 |
ASX - By Stock
|
1.3K
|
703K
|
29
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
hottod
|
1.3K |
703K |
39 |
20/01/24 |
20/01/24 |
ASX - By Stock
|
1.3K
|
703K
|
39
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
hottod
|
1.3K |
703K |
22 |
20/01/24 |
20/01/24 |
ASX - By Stock
|
1.3K
|
703K
|
22
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
hottod
|
12K |
6.2M |
39 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
12K
|
6.2M
|
39
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
hottod
|
1.3K |
703K |
65 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
1.3K
|
703K
|
65
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
hottod
|
1.3K |
703K |
10 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
1.3K
|
703K
|
10
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
hottod
|
1.3K |
703K |
18 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
1.3K
|
703K
|
18
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
hottod
|
1.3K |
703K |
14 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
1.3K
|
703K
|
14
|
|
ASX - By Stock
|
NEU |
The NDD box seat
|
|
hottod
|
13 |
9.5K |
174 |
14/01/24 |
14/01/24 |
ASX - By Stock
|
13
|
9.5K
|
174
|
|
ASX - By Stock
|
NEU |
Re:
PHASE2 PRADER WILLI SYNDROME START !!!!
|
|
hottod
|
42 |
32K |
60 |
12/01/24 |
12/01/24 |
ASX - By Stock
|
42
|
32K
|
60
|
|
ASX - By Stock
|
NEU |
Re:
Acadia got Rof Trofenitde AND Global rights for NNZ-2591 for RETT/Fragile X
|
|
hottod
|
44 |
19K |
24 |
10/01/24 |
10/01/24 |
ASX - By Stock
|
44
|
19K
|
24
|
|
ASX - By Stock
|
NEU |
Re:
Merck to acquire Prometheus in a US$ 10.8 b deal
|
|
hottod
|
108 |
65K |
47 |
10/01/24 |
10/01/24 |
ASX - By Stock
|
108
|
65K
|
47
|
|
ASX - By Stock
|
NEU |
Re:
Merck to acquire Prometheus in a US$ 10.8 b deal
|
|
hottod
|
108 |
65K |
49 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
108
|
65K
|
49
|
|
ASX - By Stock
|
NEU |
Re:
Merck to acquire Prometheus in a US$ 10.8 b deal
|
|
hottod
|
108 |
65K |
59 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
108
|
65K
|
59
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
hottod
|
1.3K |
703K |
122 |
08/01/24 |
08/01/24 |
ASX - By Stock
|
1.3K
|
703K
|
122
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Completion of enrolment in Neuren's Angelman P2 trial
|
|
hottod
|
52 |
35K |
51 |
04/01/24 |
04/01/24 |
ASX - By Stock
|
52
|
35K
|
51
|
|
ASX - By Stock
|
NEU |
Re:
ANAVEX MEETS ENDPOINTS PHASE2 RETT
|
|
hottod
|
166 |
78K |
30 |
04/01/24 |
04/01/24 |
ASX - By Stock
|
166
|
78K
|
30
|
|
ASX - By Stock
|
NEU |
Re:
ANAVEX MEETS ENDPOINTS PHASE2 RETT
|
|
hottod
|
166 |
78K |
26 |
03/01/24 |
03/01/24 |
ASX - By Stock
|
166
|
78K
|
26
|
|